Specimen obtained by Whipple's pancreaticoduodenectomy was sent for histopathological examination. The cut section of the patient's pancreas revealed the presence of an infiltrating tumour measuring 3.0 cm × 2.5 cm with yellow-tan areas (Fig. 1) .
INTRODUCTION
A final diagnosis of lipid-rich variant of PET -welldifferentiated neuroendocrine carcinoma -was made based on our histological and immunohistochemical findings. The patient recovered well, and was symptom-free at his last follow-up.
DISCUS SION
PETs are rare tumours with variable and complex morphology, and can be clinically functional or nonfunctional. Functional endocrine tumours are easier to distinguish from other nonendocrine pancreatic primary and metastatic tumours.
Nonfunctioning tumours, however, pose a dilemma to the pathologist, who has to consider the complex variants of PETs and the plethora of PET mimics. Functional tumours are usually small, as they present early with syndromic manifestations related to the secreted hormone (e.g. insulinoma, gastrinoma, VIPoma, glucagonoma, somatostatinoma and pancreatic polypeptidoma).
Nonfunctional tumours usually present late with symptoms related to mass effect.
A wide variety of imaging methods have been described in the literature for the localisation of PETs and detection of metastases, including CT, magnetic resonance imaging, Lipid-rich variant of PET was first described by Ordonez and Silva in 1997 (9) as a distinct subtype of PET. Singh et al (7) had, in their landmark study of this category, differentiated this lesion This feature was suggested as a marker in cases of metastasis, especially to the liver. Ultrastructurally, these tumour cells show lipid droplets, dilated cisterns of endoplasmic reticulum and dense core neurosecretory granules. (7, 9) In the present case, the various differential diagnoses The World Health Organization's classification of PET (11) categorises these tumours into four groups: (a) well-differentiated, 
